BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 12798851)

  • 1. Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases.
    Bayry J; Misra N; Latry V; Prost F; Delignat S; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
    Transfus Clin Biol; 2003 Jun; 10(3):165-9. PubMed ID: 12798851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of intravenous immunoglobulin action in the treatment of autoimmune disorders.
    Larroche C; Chanseaud Y; Garcia de la Pena-Lefebvre P; Mouthon L
    BioDrugs; 2002; 16(1):47-55. PubMed ID: 11909001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of intravenous polyclonal immunoglobulins in autoimmune and inflammatory disorders].
    Graff-Dubois S; Sibéril S; Elluru S; Negi VS; Delignat S; Mouthon L; Lacroix-Desmazes S; Kazatchkine MD; Bayary J; Kaveri SV
    Transfus Clin Biol; 2007 May; 14(1):63-8. PubMed ID: 17498995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanisms of action of intravenous immunoglobulins in the treatment of autoimmune diseases].
    Mouthon L; Hurez V; Kazatchkine M
    Ann Med Interne (Paris); 1993; 144(8):506-13. PubMed ID: 8179238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin in autoimmune and inflammatory diseases: more than mere transfer of antibodies.
    Sibéril S; Elluru S; Negi VS; Ephrem A; Misra N; Delignat S; Bayary J; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
    Transfus Apher Sci; 2007 Aug; 37(1):103-7. PubMed ID: 17765663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunomodulatory effects of intravenous immunoglobulins].
    Kazatchkine M; Mouthon L; Kaveri SV
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S13-8. PubMed ID: 10896983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunomodulatory effects of intravenous immunoglobulins in autoimmune diseases].
    Mouthon L; Lacroix-Desmazes S; Pashov A; Kaveri SV; Kazatchkine MD
    Rev Med Interne; 1999; 20 Suppl 4():423s-430s. PubMed ID: 10522317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic intravenous immunoglobulins.
    Lemieux R; Bazin R; Néron S
    Mol Immunol; 2005 May; 42(7):839-48. PubMed ID: 15829272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of autoimmune responses by intravenous immunoglobulin (IVIg).
    Kaveri S; Prasad N; Vassilev T; Hurez V; Pashov A; Lacroix-Desmazes S; Kazatchkine M
    Mult Scler; 1997 Apr; 3(2):121-8. PubMed ID: 9291165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulins in immunodeficiencies: more than mere replacement therapy.
    Kaveri SV; Maddur MS; Hegde P; Lacroix-Desmazes S; Bayry J
    Clin Exp Immunol; 2011 Jun; 164 Suppl 2(Suppl 2):2-5. PubMed ID: 21466545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanisms of immunoglobulins activity].
    Kowalczyk D
    Pol Merkur Lekarski; 2011 Jun; 30(180):397-9. PubMed ID: 21751546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of action of intravenous immunoglobulins.
    Baerenwaldt A; Biburger M; Nimmerjahn F
    Expert Rev Clin Immunol; 2010 May; 6(3):425-34. PubMed ID: 20441428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulation of autoimmune and inflammatory diseases with intravenous immunoglobulin.
    Ephrem A; Misra N; Hassan G; Dasgupta S; Delignat S; Duong Van Huyen JP; Chamat S; Prost F; Lacroix-Desmazes S; Kavery SV; Kazatchkine MD
    Clin Exp Med; 2005 Dec; 5(4):135-40. PubMed ID: 16362793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Indications and mechanisms of action of the intravenous immunoglobulines in the systemic autoimmune and inflammatory pathologies].
    Mouthon L; Bussone G; Kaveri S
    Rev Med Interne; 2009 Dec; 30(12 Suppl):H14-20. PubMed ID: 19995651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory diseases.
    Ballow M
    J Allergy Clin Immunol; 1997 Aug; 100(2):151-7. PubMed ID: 9275133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin (IVIg) in the treatment of autoimmune and inflammatory diseases.
    Ruiz de Souza V; Kaveri SV; Kazatchkine MD
    Clin Exp Rheumatol; 1993; 11 Suppl 9():S33-6. PubMed ID: 8354005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders.
    Ballow M
    J Allergy Clin Immunol; 2011 Feb; 127(2):315-23; quiz 324-5. PubMed ID: 21185071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intravenous immunoglobulins in autoimmune and inflammatory disorders: beyond a simple substitution].
    Galeotti C; Maddur MS; Kazatchkine MD; Mouthon L; Kaveri SV
    Transfus Clin Biol; 2009 May; 16(2):75-9. PubMed ID: 19443254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IVIG in autoimmune disease - Potential next generation biologics.
    Zuercher AW; Spirig R; Baz Morelli A; Käsermann F
    Autoimmun Rev; 2016 Aug; 15(8):781-5. PubMed ID: 27019051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of action of intravenous immunoglobulin (IVIG).
    Kazatchkine MD; Bellon B; Kaveri SV
    Mult Scler; 2000 Oct; 6 Suppl 2():S24-6; discussion S33. PubMed ID: 11188775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.